M. KARACAN Et Al. , "Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders," 17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı , LOZAN, Switzerland, 2001
KARACAN, M. Et Al. 2001. Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders. 17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı , (LOZAN, Switzerland).
KARACAN, M., DEMİRCAN, A., KARABULUT, O., KERVANCIOĞLU, M. E., & BENHABİB, M., (2001). Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders . 17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı, LOZAN, Switzerland
KARACAN, MERİÇ Et Al. "Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders," 17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı, LOZAN, Switzerland, 2001
KARACAN, MERİÇ Et Al. "Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders." 17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı , LOZAN, Switzerland, 2001
KARACAN, M. Et Al. (2001) . "Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders." 17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı , LOZAN, Switzerland.
@conferencepaper{conferencepaper, author={MERİÇ KARACAN Et Al. }, title={Cessation of gonadotrophin-releasing hormone (GnRH) agonist therapy combined with high-dose urinary gonadotrophins does not improve the outcome of IVF-ET cycle in poor responders}, congress name={17th Annual Meeting of European Society of Human Reproduction and Embryology konferansı}, city={LOZAN}, country={Switzerland}, year={2001}}